222 related articles for article (PubMed ID: 30530607)
1. Role of the Hydrophobic Bridge in the Carbapenemase Activity of Class D β-Lactamases.
Stewart NK; Smith CA; Antunes NT; Toth M; Vakulenko SB
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530607
[TBL] [Abstract][Full Text] [Related]
2. Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.
Smith CA; Stewart NK; Toth M; Vakulenko SB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358584
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
5. Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.
Schneider KD; Ortega CJ; Renck NA; Bonomo RA; Powers RA; Leonard DA
J Mol Biol; 2011 Mar; 406(4):583-94. PubMed ID: 21215758
[TBL] [Abstract][Full Text] [Related]
6. Multiple substitutions lead to increased loop flexibility and expanded specificity in
Harper TM; June CM; Taracila MA; Bonomo RA; Powers RA; Leonard DA
Biochem J; 2018 Jan; 475(1):273-288. PubMed ID: 29229762
[TBL] [Abstract][Full Text] [Related]
7. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
Esterly JS; Qi C; Malczynski M; Scheetz MH
Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of phenotypic-based detection assays for carbapenemase-producing Acinetobacter baumannii with a proposed algorithm in resource-limited settings.
Khuntayaporn P; Thirapanmethee K; Kanathum P; Chitsombat K; Chomnawang MT
PLoS One; 2021; 16(11):e0259686. PubMed ID: 34735533
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
Marti S; Sánchez-Céspedes J; Alba V; Vila J
Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
[TBL] [Abstract][Full Text] [Related]
10. Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates.
Terzi HA; Atasoy AR; Aykan SB; Karakece E; Asık G; Ciftci IH
Saudi Med J; 2016 Jan; 37(1):43-7. PubMed ID: 26739973
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility in carbapenem hydrolysis drives substrate specificity of the class D carbapenemase OXA-24/40.
Mitchell JM; June CM; Baggett VL; Lowe BC; Ruble JF; Bonomo RA; Leonard DA; Powers RA
J Biol Chem; 2022 Jul; 298(7):102127. PubMed ID: 35709986
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking, dynamics and free energy analyses of
Ramachandran B; Jeyakanthan J; Lopes BS
J Med Microbiol; 2020 Aug; 69(8):1062-1078. PubMed ID: 32773005
[No Abstract] [Full Text] [Related]
13. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
[TBL] [Abstract][Full Text] [Related]
14. Complete sequence of carbapenem-resistant
Hayashi W; Kaiju H; Kayama S; Yu L; Zuo H; Sugawara Y; Azuma K; Takahashi A; Hata Y; Sugai M
Microbiol Spectr; 2024 Apr; 12(4):e0391923. PubMed ID: 38483476
[TBL] [Abstract][Full Text] [Related]
15. Arginine Modulates Carbapenem Deactivation by OXA-24/40 in Acinetobacter baumannii.
VanPelt J; Stoffel S; Staude MW; Dempster K; Rose HA; Graney S; Graney E; Braynard S; Kovrigina E; Leonard DA; Peng JW
J Mol Biol; 2021 Sep; 433(19):167150. PubMed ID: 34271009
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
Brown S; Young HK; Amyes SG
Clin Microbiol Infect; 2005 Jan; 11(1):15-23. PubMed ID: 15649299
[TBL] [Abstract][Full Text] [Related]
17. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
18. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Hu WS; Yao SM; Fung CP; Hsieh YP; Liu CP; Lin JF
Antimicrob Agents Chemother; 2007 Nov; 51(11):3844-52. PubMed ID: 17724156
[TBL] [Abstract][Full Text] [Related]
19. Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
Wan D; Jing X; Zhou H; Min X; Zhang X; Wu T; Liu R; Zeng J
J Infect Chemother; 2020 Jun; 26(6):636-639. PubMed ID: 32173284
[TBL] [Abstract][Full Text] [Related]
20. Loss of the 29-kilodalton outer membrane protein in the presence of OXA-51-like enzymes in Acinetobacter baumannii is associated with decreased imipenem susceptibility.
Jeong HW; Cheong HJ; Kim WJ; Kim MJ; Song KJ; Song JW; Kim HS; Roh KH
Microb Drug Resist; 2009 Sep; 15(3):151-8. PubMed ID: 19728771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
